癌症
分级(工程)
癌基因
骨肉瘤
生物标志物
癌症研究
机制(生物学)
医学
临床意义
生物
病理
内科学
细胞周期
遗传学
认识论
哲学
生态学
作者
Xin Yang,Hai-Yang Liao,Haihong Zhang
标识
DOI:10.1016/j.cca.2021.12.017
摘要
The MET proto-oncogene was first identified in osteosarcoma cells exposed to carcinogens. Although expressed in many normal cells, MET is overexpressed in many human cancers. MET is involved in the initiation and development of various human cancers and mediates proliferation, migration and invasion. Accordingly, MET has been successfully used as a biomarker for diagnosis and prognosis, survival, post-operative recurrence, risk assessment and pathologic grading, as well as a therapeutic target. In addition, recent work indicates that inhibition of MET expression and function has potential clinical benefit. This review summarizes the role, mechanism, and clinical significance of MET in the formation and development of human cancer.
科研通智能强力驱动
Strongly Powered by AbleSci AI